Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
FDA targets synthetic kratom compound, citing potential dangers and unregulated sales.
US health officials are taking action against kratom-related products due to industry complaints over unregulated sales and potential health risks.
The FDA specifically targets 7-hydroxymitragynine, a synthetic form of kratom, warning it could be more potent than morphine.
The agency recommends adding it to the list of highly restricted drugs, and has issued warnings to companies making unproven health claims.
The crackdown aims to protect consumers amid growing concerns about the safety and abuse of kratom.
145 Articles
La FDA tiene como objetivo el compuesto sintético de kratom, citando peligros potenciales y ventas no reguladas.